JP2024518319A5 - - Google Patents
Info
- Publication number
- JP2024518319A5 JP2024518319A5 JP2023565467A JP2023565467A JP2024518319A5 JP 2024518319 A5 JP2024518319 A5 JP 2024518319A5 JP 2023565467 A JP2023565467 A JP 2023565467A JP 2023565467 A JP2023565467 A JP 2023565467A JP 2024518319 A5 JP2024518319 A5 JP 2024518319A5
- Authority
- JP
- Japan
- Prior art keywords
- acid
- organic solvent
- radiopharmaceutical composition
- proportion
- mobile phase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2105950.6A GB202105950D0 (en) | 2021-04-26 | 2021-04-26 | Analytical HPLC |
| GB2105950.6 | 2021-04-26 | ||
| PCT/EP2022/061004 WO2022229155A1 (en) | 2021-04-26 | 2022-04-26 | Analytical hplc |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024518319A JP2024518319A (ja) | 2024-05-01 |
| JP2024518319A5 true JP2024518319A5 (cg-RX-API-DMAC7.html) | 2025-05-09 |
Family
ID=76193425
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023565467A Pending JP2024518319A (ja) | 2021-04-26 | 2022-04-26 | 分析用hplc |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20240302338A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4330662B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024518319A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240000562A (cg-RX-API-DMAC7.html) |
| CN (1) | CN117222890A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022264815A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3217818A1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES3050308T3 (cg-RX-API-DMAC7.html) |
| GB (1) | GB202105950D0 (cg-RX-API-DMAC7.html) |
| IL (1) | IL307946A (cg-RX-API-DMAC7.html) |
| PL (1) | PL4330662T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022229155A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201915206D0 (en) * | 2019-10-21 | 2019-12-04 | Ge Healthcare Ltd | Use of cyclodextrins as a radiostabilizer |
| CN119688861A (zh) * | 2024-11-29 | 2025-03-25 | 中国辐射防护研究院 | 一种生物样本中18f-psma-1007放化纯的液相色谱分析方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5300280A (en) * | 1992-02-14 | 1994-04-05 | Mallinckrodt Medical, Inc. | Stabilized radiopharmaceutical kits |
| SI2301587T1 (sl) * | 2002-03-01 | 2014-11-28 | Dyax Corp. | KDR in VEGF/KDR vezavni peptidi in njihova uporaba pri diagnozi |
| JP4942953B2 (ja) * | 2005-06-30 | 2012-05-30 | サントリーホールディングス株式会社 | プロシアニジンの分析方法 |
| US8214159B2 (en) * | 2008-12-04 | 2012-07-03 | Siemens Medical Solutions Usa, Inc. | Apparatus and method for automated quality control |
| GB201013808D0 (en) * | 2010-08-18 | 2010-09-29 | Ge Healthcare Ltd | Peptide radiotracer compositions |
| EP2450332A1 (en) * | 2010-10-22 | 2012-05-09 | Bayer Pharma Aktiengesellschaft | Compounds for use in Imaging, diagnosing and/or treatment of diseases of the central nervous system (F-D2-Deprenyl) |
| GB201202420D0 (en) * | 2012-02-13 | 2012-03-28 | Ge Healthcare Ltd | Radiotracer compositions |
| CA2869398C (en) * | 2012-04-10 | 2019-10-22 | Lantheus Medical Imaging, Inc. | Radiopharmaceutical synthesis methods |
| DK2882863T3 (da) * | 2012-08-13 | 2021-10-11 | Massachusetts Gen Hospital | System og fremgangsmåde til kvantitativ billeddannelse af mitokondriekompleks 1 |
| GB201303830D0 (en) * | 2013-03-04 | 2013-04-17 | Univ Glasgow | Methods,unit and device relating to the manufacture,processing,synthesising or screening of radiopharmaceutical compositions |
| GB201418893D0 (en) * | 2014-10-23 | 2014-12-10 | Univ Hull | Monolithic body |
| GB201805253D0 (en) * | 2018-03-29 | 2018-05-16 | Ge Healthcare Ltd Ip | Solid phase extraction |
| CN111333638A (zh) * | 2020-03-17 | 2020-06-26 | 四川大学华西医院 | 18f标记的异喹啉并哒嗪酮类化合物及其合成方法和应用 |
-
2021
- 2021-04-26 GB GBGB2105950.6A patent/GB202105950D0/en not_active Ceased
-
2022
- 2022-04-26 EP EP22725757.3A patent/EP4330662B1/en active Active
- 2022-04-26 ES ES22725757T patent/ES3050308T3/es active Active
- 2022-04-26 US US18/557,528 patent/US20240302338A1/en active Pending
- 2022-04-26 IL IL307946A patent/IL307946A/en unknown
- 2022-04-26 WO PCT/EP2022/061004 patent/WO2022229155A1/en not_active Ceased
- 2022-04-26 PL PL22725757.3T patent/PL4330662T3/pl unknown
- 2022-04-26 KR KR1020237040178A patent/KR20240000562A/ko active Pending
- 2022-04-26 AU AU2022264815A patent/AU2022264815A1/en active Pending
- 2022-04-26 CA CA3217818A patent/CA3217818A1/en active Pending
- 2022-04-26 JP JP2023565467A patent/JP2024518319A/ja active Pending
- 2022-04-26 CN CN202280031268.4A patent/CN117222890A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bowden et al. | Scalable 18F processing conditions for copper-mediated radiofluorination chemistry facilitate DoE optimization studies and afford an improved synthesis of [18F] olaparib | |
| Wester et al. | Synthesis and radiopharmacology of O-(2-[18F] fluoroethyl)-L-tyrosine for tumor imaging | |
| Liu et al. | A new 18F-heteroaryltrifluoroborate radio-prosthetic with greatly enhanced stability that is labelled by 18F–19F-isotope exchange in good yield at high specific activity | |
| EP3212610B1 (en) | Methods for low temperature fluorine-18 radiolabeling of biomolecules | |
| JP2022136074A (ja) | 新規製剤及び合成方法 | |
| Adam et al. | Fluorination of aromatic compounds with F2 and acetyl hypofluorite: synthesis of 18F-aryl fluorides by cleavage of aryl-tin bonds [1] | |
| CN103249698B (zh) | 固相萃取方法 | |
| Zhang et al. | Development of an automated system for synthesizing 18F-labeled compounds using [18F] fluoroethyl bromide as a synthetic precursor | |
| US8968701B2 (en) | Usage of low to medium-pressure liquid chromatography for the purification of radiotracers | |
| US20040260073A1 (en) | Methods for purifying radiolabelled compounds | |
| Martinez et al. | Al [18F] F-complexation of DFH17, a NOTA-conjugated adrenomedullin analog, for PET imaging of pulmonary circulation | |
| JP2025116040A (ja) | 放射性金属錯体の製造方法 | |
| EP4330662B1 (en) | Analytical hplc | |
| JP2021515005A5 (cg-RX-API-DMAC7.html) | ||
| CN110305004B (zh) | 放射性碘标记15-(4-碘苯基)-3(r,s)-甲基十五烷酸的制造方法 | |
| Wei et al. | Synthesis and characterization of 123I-CMICE-013: a potential SPECT myocardial perfusion imaging agent | |
| JP2024522770A5 (cg-RX-API-DMAC7.html) | ||
| Pekošak et al. | Improved synthesis and application of [11C] benzyl iodide in positron emission tomography radiotracer production | |
| US20110091982A1 (en) | Detection and Quantification of Anions | |
| CN102126985A (zh) | 18f标记前体化合物及其制备方法和应用 | |
| US20200047158A1 (en) | Solid phase conditioning | |
| Ryzhikov et al. | Preparation of [18F] flumazenil, a potential radioligand for PET imaging of central benzodiazepine receptors, by isotope exchange | |
| WO2018164043A1 (ja) | 放射性フッ素標識前駆体化合物及びそれを用いた放射性フッ素標識化合物の製造方法 | |
| US10695450B2 (en) | Synthesis of a radioactive agent composition | |
| HK40109526B (en) | Analytical hplc |